DJS Antibodies

About:

DJS Antibodies designs and discovers novel therapeutic monoclonal antibodies against GPCRs.

Website: http://www.djsantibodies.com/

Top Investors: Innovate UK, LifeArc, Oxford Science Enterprises, Sedgwick Claims Management Services, Amgen Ventures

Description:

DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. The company's breakthrough technology enables its to produce first-in-class antibody therapeutics to previously intractable disease targets.